Clinical Trial Update: The Effects of Pentoxifylline on PAI-1 in an Obese Population [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of pentoxifylline on PAI-1 levels in adults with obesity; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Vanderbilt University | Conditions: Obesity | Phase 4 | Status: COMPLETED | Results posted: 2017-11-30